Robert Naclerio to Rhinitis, Allergic, Seasonal
This is a "connection" page, showing publications Robert Naclerio has written about Rhinitis, Allergic, Seasonal.
Connection Strength
11.293
-
A clinical trial of a microcrystalline cellulose topical nasal spray on the acute response to allergen challenge. Am J Rhinol Allergy. 2016 Jul; 30(4):269-73.
Score: 0.528
-
Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms. Am J Rhinol Allergy. 2013 Jan; 27(1):48-53.
Score: 0.414
-
Evidence of maxillary sinus inflammation in seasonal allergic rhinitis. Otolaryngol Head Neck Surg. 2012 Jun; 146(6):880-6.
Score: 0.389
-
Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis: a white paper. Allergy Asthma Proc. 2011 Mar-Apr; 32(2):168-77.
Score: 0.364
-
Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):55-63.
Score: 0.361
-
Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009 Jun; 123(6):1342-8.
Score: 0.322
-
Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis? Allergy Asthma Proc. 2009 Mar-Apr; 30(2):212-3; author reply 213-4.
Score: 0.318
-
Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008 May; 121(5):1126-1132.e7.
Score: 0.298
-
Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
Score: 0.296
-
Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis. Otolaryngol Head Neck Surg. 2008 Feb; 138(2):129-39.
Score: 0.295
-
Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc. 2008 Jan-Feb; 29(1):24-8.
Score: 0.293
-
Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders. MedGenMed. 2007 Aug 15; 9(3):35.
Score: 0.285
-
Patient and physician perspectives on the attributes of nasal allergy medications. Allergy Asthma Proc. 2007 May-Jun; 28 Suppl 1:S11-7.
Score: 0.280
-
Desloratadine partially inhibits the augmented bacterial responses in the sinuses of allergic and infected mice. Clin Exp Allergy. 2004 Oct; 34(10):1649-54.
Score: 0.234
-
Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med. 2001 Nov 26; 161(21):2581-7.
Score: 0.192
-
Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):193-9.
Score: 0.181
-
Natural and induced allergic responses increase the ability of the nose to warm and humidify air. J Allergy Clin Immunol. 2000 Dec; 106(6):1045-52.
Score: 0.179
-
Hot, humid air partially inhibits the nasal response to allergen provocation. Arch Otolaryngol Head Neck Surg. 2000 Jun; 126(6):749-54.
Score: 0.173
-
As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2000 Apr; 105(4):732-8.
Score: 0.171
-
Clinical manifestations of the release of histamine and other inflammatory mediators. J Allergy Clin Immunol. 1999 Mar; 103(3 Pt 2):S382-5.
Score: 0.159
-
Optimizing treatment options. Clin Exp Allergy. 1998 Dec; 28 Suppl 6:54-9.
Score: 0.156
-
Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
Score: 0.148
-
A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997 Sep; 100(3):293-300.
Score: 0.143
-
Ragweed allergic rhinitis and the paranasal sinuses. A computed tomographic study. Arch Otolaryngol Head Neck Surg. 1997 Feb; 123(2):193-6.
Score: 0.138
-
Treatment with hot, humid air reduces the nasal response to allergen challenge. J Allergy Clin Immunol. 1997 Jan; 99(1 Pt 1):77-86.
Score: 0.137
-
Lack of effect of hot, humid air on response to nasal challenge with histamine. Ann Otol Rhinol Laryngol. 1996 Feb; 105(2):146-54.
Score: 0.128
-
Local nasal immunotherapy. Has the time come? Am J Respir Crit Care Med. 1995 Aug; 152(2):425-6.
Score: 0.124
-
The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage. Am J Respir Crit Care Med. 1995 Jan; 151(1):136-44.
Score: 0.119
-
Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 2):1303-9.
Score: 0.118
-
Observations on the response of the nasal mucosa to allergens. Otolaryngol Head Neck Surg. 1994 Sep; 111(3 Pt 2):355-63.
Score: 0.116
-
Seasonal allergic rhinitis affects sinonasal microbiota. Am J Rhinol Allergy. 2014 Jul-Aug; 28(4):281-6.
Score: 0.115
-
Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
Score: 0.114
-
Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine. Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):660-6.
Score: 0.112
-
Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol. 1993 Nov; 92(5):717-21.
Score: 0.110
-
Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration. J Appl Physiol (1985). 2013 Nov 01; 115(9):1262-7.
Score: 0.108
-
The effect of antihistamines on the immediate allergic response: a comparative review. Otolaryngol Head Neck Surg. 1993 Jun; 108(6):723-30.
Score: 0.107
-
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012 Nov; 130(5):1049-62.
Score: 0.102
-
Evaluation of a bedtime dose of a combination antihistamine/analgesic/decongestant product on antigen challenge the next morning. Laryngoscope. 1992 Mar; 102(3):330-4.
Score: 0.098
-
Fireside conference 7. Immunotherapy for allergic rhinitis. Rhinol Suppl. 1992; 14:209-12.
Score: 0.097
-
The impact of immunotherapy on the pathophysiology of ragweed pollen allergy. Rhinol Suppl. 1992; 14:52-6.
Score: 0.097
-
Airways, allergy, sinus. Otolaryngol Head Neck Surg. 1992 Jan; 106(1):20.
Score: 0.097
-
Allergic rhinitis. N Engl J Med. 1991 Sep 19; 325(12):860-9.
Score: 0.095
-
Antigen-provoked increase in histamine reactivity. Observations on mechanisms. Am Rev Respir Dis. 1991 Sep; 144(3 Pt 1):642-8.
Score: 0.094
-
The nasal allergic reaction: observations on the role of histamine. Clin Exp Allergy. 1991 May; 21 Suppl 2:13-9.
Score: 0.092
-
Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.
Score: 0.091
-
Localized antigen challenge of the nasal mucosa. Arch Otolaryngol Head Neck Surg. 1990 Dec; 116(12):1407-10.
Score: 0.090
-
Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen. Clin Exp Allergy. 1990 Nov; 20(6):701-5.
Score: 0.089
-
An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis. Allergy Asthma Proc. 2010 Nov-Dec; 31(6):483-92.
Score: 0.089
-
The role of histamine in allergic rhinitis. J Allergy Clin Immunol. 1990 Oct; 86(4 Pt 2):628-32.
Score: 0.089
-
Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010 Jul-Aug; 24(4):286-90.
Score: 0.087
-
The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg. 1990 Mar; 102(3):219-24.
Score: 0.085
-
The congestion quantifier five-item test for nasal congestion: refinement of the congestion quantifier seven-item test. Am J Rhinol Allergy. 2010 Jan-Feb; 24(1):34-8.
Score: 0.084
-
The effect of cetirizine on early allergic response. Laryngoscope. 1989 Jun; 99(6 Pt 1):596-9.
Score: 0.081
-
The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol. 1988 Nov; 82(5 Pt 2):927-34.
Score: 0.078
-
The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis. 1988 Aug; 138(2):406-12.
Score: 0.076
-
Experimentally induced nasal allergic responses. J Allergy Clin Immunol. 1988 May; 81(5 Pt 2):940-9.
Score: 0.075
-
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008 Apr; 63 Suppl 86:8-160.
Score: 0.075
-
Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11; 316(24):1506-10.
Score: 0.070
-
Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007 Jun; 119(6):1430-7.
Score: 0.070
-
Arachidonic acid metabolites during nasal challenge. Arch Otolaryngol Head Neck Surg. 1987 Feb; 113(2):179-83.
Score: 0.069
-
Theophylline reduces histamine release during pollen-induced rhinitis. J Allergy Clin Immunol. 1986 Nov; 78(5 Pt 1):874-6.
Score: 0.068
-
Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy. 2006 Sep; 61(9):1086-96.
Score: 0.067
-
The role of inflammatory mediators in allergic rhinitis. Ear Nose Throat J. 1986 May; 65(5):206-12.
Score: 0.065
-
Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2006 Feb; 132(2):164-72.
Score: 0.064
-
Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11; 313(2):65-70.
Score: 0.062
-
Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004 Jan; 92(1):73-9.
Score: 0.056
-
Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983 Oct; 128(4):597-602.
Score: 0.055
-
Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2003 May; 129(5):557-62.
Score: 0.053
-
Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy. 2003 Mar; 58(3):192-7.
Score: 0.052
-
In vivo demonstration of inflammatory mediator release following nasal challenge with antigen. Eur J Respir Dis Suppl. 1983; 128 (Pt 1):26-32.
Score: 0.052
-
Effects of intranasal azelastine on the response to nasal allergen challenge. Laryngoscope. 2002 Jan; 112(1):47-52.
Score: 0.048
-
Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin Allergy Immunol. 2002; 17:101-39.
Score: 0.048
-
Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen. Clin Exp Allergy. 2001 Dec; 31(12):1913-22.
Score: 0.048
-
The nasal passage of subjects with asthma has a decreased ability to warm and humidify inspired air. Am J Respir Crit Care Med. 2001 Nov 01; 164(9):1640-6.
Score: 0.048
-
Dose-dependent effects of intranasal steroids: how relevant? Ann Allergy Asthma Immunol. 2000 Oct; 85(4):248-9.
Score: 0.044
-
Warming of feet elevates nasal mucosal surface temperature and reduces the early response to nasal challenge with allergen. J Allergy Clin Immunol. 1999 Aug; 104(2 Pt 1):285-93.
Score: 0.041
-
A technique to measure the ability of the human nose to warm and humidify air. J Appl Physiol (1985). 1999 Jul; 87(1):400-6.
Score: 0.041
-
Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
Score: 0.036
-
Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction. Ann Allergy Asthma Immunol. 1997 Mar; 78(3):307-12.
Score: 0.035
-
Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils. Pulm Pharmacol Ther. 1997; 10(2):97-104.
Score: 0.034
-
Characterization of phospholipase A2 from human nasal lavage. Am J Respir Cell Mol Biol. 1994 Jul; 11(1):108-13.
Score: 0.029
-
Dual function of novel pollen coat (surface) proteins: IgE-binding capacity and proteolytic activity disrupting the airway epithelial barrier. PLoS One. 2013; 8(1):e53337.
Score: 0.026
-
The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol. 1992 Jul; 90(1):85-91.
Score: 0.025
-
Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol. 1991 Jul; 88(1):27-32.
Score: 0.023
-
Additional properties of cetirizine, a new H1 antagonist. Allergy Proc. 1991 May-Jun; 12(3):187-91.
Score: 0.023
-
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy. 2010 Oct; 65(10):1212-21.
Score: 0.022
-
Effect of ozone inhalation on the response to nasal challenge with antigen of allergic subjects. Am Rev Respir Dis. 1990 Sep; 142(3):594-601.
Score: 0.022
-
Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy. 1990 Sep; 20(5):491-500.
Score: 0.022
-
Ragweed IgE and IgG4 antibody in nasal secretions during immunotherapy. Clin Exp Allergy. 1990 Sep; 20(5):571-9.
Score: 0.022
-
Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis. 1990 Jul; 142(1):167-71.
Score: 0.022
-
Effects of a single-dose pretreatment with captopril on the immediate response to nasal challenge with allergen. Int Arch Allergy Appl Immunol. 1990; 93(2-3):165-70.
Score: 0.021
-
Studies on the allergic and nonallergic nasal inflammation. J Allergy Clin Immunol. 1988 May; 81(5 Pt 1):782-90.
Score: 0.019
-
The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction. Allergy. 1987 Oct; 42(7):496-501.
Score: 0.018
-
Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. J Immunol. 1987 Jan 15; 138(2):428-34.
Score: 0.017
-
Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1986 Nov; 134(5):1102.
Score: 0.017
-
Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol. 1986 Aug 15; 137(4):1323-8.
Score: 0.017
-
Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol. 1986 Aug 01; 137(3):977-82.
Score: 0.017
-
Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy. 1986 Mar; 16(2):101-10.
Score: 0.016
-
Kininogens in nasal secretions after allergen challenge. Adv Exp Med Biol. 1986; 198 Pt B:189-92.
Score: 0.016
-
Kinins as mediators of human allergic reactions. Adv Exp Med Biol. 1986; 198 Pt B:181-7.
Score: 0.016
-
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest. 1985 Dec; 76(6):2247-53.
Score: 0.016
-
Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984 Jun 21; 310(25):1626-30.
Score: 0.014
-
Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov; 72(5):1678-85.
Score: 0.014
-
Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
Score: 0.013
-
Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy. J Allergy Clin Immunol. 1992 Feb; 89(2):519-29.
Score: 0.006
-
Responses to ragweed-pollen nasal challenge before and after immunotherapy. J Allergy Clin Immunol. 1989 Aug; 84(2):197-205.
Score: 0.005
-
Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA. 1986 Jan 10; 255(2):225-9.
Score: 0.004